Screener
Travere Therapeutics, Inc. TVTX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Assets | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 87,302 | 80,134 |
| Inventory | 6,356 | 5,875 |
| Prepaid expenses and other current assets | 34,347 | 28,760 |
| Total current assets | 392,681 | 437,565 |
| Long-term inventory | 30,698 | 30,280 |
| Property and equipment, net | 3,627 | 4,022 |
| Operating lease right of use assets | 9,668 | 10,576 |
| Intangible assets, net | 110,038 | 113,868 |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s total current assets?
- Travere Therapeutics, Inc. (TVTX) reported total current assets of $392.68M in Q1 2026.
- How has Travere Therapeutics, Inc.'s total current assets changed year-over-year?
- Travere Therapeutics, Inc.'s total current assets increased by 4.9% year-over-year, from $374.17M to $392.68M.
- What is the long-term trend for Travere Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s total current assets has grown at a 1.3% compound annual growth rate (CAGR), from $410.41M to $437.57M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Travere Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude